Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
FDA Removes GHK-Cu from Category 2: What Peptide Users Need to Know On April 15, 2026, the FDA announced a significant regulatory update: injectable GHK-Cu (copper tripeptide-1) will be removed from the Category 2 bulk substances list by July 2026
Interlinks Additional Resources For more information, you can visit various websites or use apps to compare prices and find discounts
NovoCare Pharmacy: Wegovy and Ozempic Direct From Novo Nordisk Novo Nordisk launched NovoCare Pharmacy in March 2025 as a direct-to-patient delivery option for Wegovy (semaglutide)
GLP-1 for sleep apnea, alcohol use and cancer risk GLP-1s may address conditions well beyond metabolic diseases: Obstructive sleep apnea: Emerging data suggest GLP-1s improve apnea symptoms. Alcohol use disorder: Patients using liraglutide or semaglutide reduced alcohol consumption by nearly two-thirds. Obesity-related cancers: An observational study of 6,000 adults found that GLP-1 receptor agonists halved the risk of obesity-related cancers compared with usual care
Purity exceeded expectations
US$ 22.48
US$ 24.64
US$ 29.14
US$ 23.03
US$ 29.33
US$ 22.25
US$ 26.36
US$ 22.79
US$ 23.95
US$ 27.05
US$ 29.23
US$ 28.26
